EHA 2015 | Future perspectives in the treatment of acute lymphoblastic leukemia
Dieter Hoelzer
At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, Frankfurt, Germany, discusses the possibilities of immunotherapy for the treatment of patients with acute lymphoblastic leukemia.
Related videos
3:36 Cost-effectiveness of CAR T-cell therapy
Carin Al Uyl-de Groot
1:54 Upcoming EBMT Annual Meeting: Prof. Nagler's ALL picks
Arnon Nagler
3:01 Academic vs. commercial CAR T-cell products
Arnon Nagler
1:29 Translation from academia to industry: manufacturing of CAR T-cells
Bruce Levine
4:23 CARCIK-CD19: allogeneic and non-viral CAR T-cells
Chiara Magnani
